These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 24481570

  • 1. Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study.
    Wang M, Tong JH, Huang DS, Zhu G, Liang GM, Du H.
    Psychopharmacology (Berl); 2014 Jul; 231(14):2811-8. PubMed ID: 24481570
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
    Katagiri H, Tohen M, McDonnell DP, Fujikoshi S, Case M, Kanba S, Takahashi M, Gomez JC.
    BMC Psychiatry; 2013 May 14; 13():138. PubMed ID: 23672672
    [Abstract] [Full Text] [Related]

  • 3. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
    Keck PE, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.
    J Clin Psychiatry; 2005 May 14; 66(5):611-6. PubMed ID: 15889948
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan 14; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov 14; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.
    Perlis RH, Baker RW, Zarate CA, Brown EB, Schuh LM, Jamal HH, Tohen M.
    J Clin Psychiatry; 2006 Nov 14; 67(11):1747-53. PubMed ID: 17196055
    [Abstract] [Full Text] [Related]

  • 7. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.
    J Clin Psychiatry; 2001 Apr 14; 62(4):273-81. PubMed ID: 11379842
    [Abstract] [Full Text] [Related]

  • 8. Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.
    Tohen M, McDonnell DP, Case M, Kanba S, Ha K, Fang YR, Katagiri H, Gomez JC.
    Br J Psychiatry; 2012 Nov 14; 201(5):376-82. PubMed ID: 22918966
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.
    Curr Med Res Opin; 2012 May 14; 28(5):701-13. PubMed ID: 22356118
    [Abstract] [Full Text] [Related]

  • 10. Effect of comorbid anxiety on treatment response in bipolar depression.
    Tohen M, Calabrese J, Vieta E, Bowden C, Gonzalez-Pinto A, Lin D, Xu W, Corya S.
    J Affect Disord; 2007 Dec 14; 104(1-3):137-46. PubMed ID: 17512607
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2003 Nov 14; 60(11):1079-88. PubMed ID: 14609883
    [Abstract] [Full Text] [Related]

  • 12. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
    Brown EB, McElroy SL, Keck PE, Deldar A, Adams DH, Tohen M, Williamson DJ.
    J Clin Psychiatry; 2006 Jul 14; 67(7):1025-33. PubMed ID: 16889444
    [Abstract] [Full Text] [Related]

  • 13. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF.
    J Clin Psychiatry; 2006 May 14; 67(5):798-806. PubMed ID: 16841630
    [Abstract] [Full Text] [Related]

  • 14. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
    Brown E, Dunner DL, McElroy SL, Keck PE, Adams DH, Degenhardt E, Tohen M, Houston JP.
    Int J Neuropsychopharmacol; 2009 Jul 14; 12(6):773-82. PubMed ID: 19079815
    [Abstract] [Full Text] [Related]

  • 15. Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients.
    Srivastava S, Wang PW, Hill SJ, Childers ME, Keller KL, Ketter TA.
    J Psychiatr Res; 2012 Jul 14; 46(7):920-6. PubMed ID: 22579071
    [Abstract] [Full Text] [Related]

  • 16. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
    Chwieduk CM, Scott LJ.
    CNS Drugs; 2011 Mar 14; 25(3):251-67. PubMed ID: 21323396
    [Abstract] [Full Text] [Related]

  • 17. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.
    Clin Ther; 2011 Nov 14; 33(11):1643-58. PubMed ID: 22054797
    [Abstract] [Full Text] [Related]

  • 18. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Nov 14; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis.
    Katagiri H, Tohen M, McDonnell DP, Fujikoshi S, Case M, Kanba S, Takahashi M, Gomez JC.
    Psychiatry Clin Neurosci; 2014 Jul 14; 68(7):498-505. PubMed ID: 24417745
    [Abstract] [Full Text] [Related]

  • 20. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Jul 14; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.